Guardian Pharmacy Raises Full-Year Guidance on Strong Q2 Performance — Guardian Pharmacy Services, Inc.

Event summary

Guardian Pharmacy reported Q2 2026 revenue of $351.8 million, up 2% YoY.
Residents served increased by 8% YoY to approximately 210,000.
Net income was $22.1 million, including an $8.5 million settlement related to a payor dispute.
Adjusted EBITDA rose to $29.7 million from $25.0 million in the prior-year period.
Company raised full-year guidance for revenue and Adjusted EBITDA.

The big picture

Guardian Pharmacy's strong Q2 performance and raised guidance reflect its ability to navigate reimbursement pressures while expanding its footprint. The company's focus on operational efficiency and strategic acquisitions positions it well in the competitive long-term care pharmacy services market. With a growing network of over 61 licensed pharmacies, Guardian is poised to benefit from continued demand for specialized pharmacy services in the aging population sector.

What we're watching

Reimbursement Pressures: How IRA-related pricing reductions will continue to impact revenue growth.
Geographic Expansion: The pace at which Guardian can integrate new acquisitions and greenfield pharmacies into its existing operations.
Operational Efficiency: Whether the company can sustain improved profitability through scale and purchasing leverage.